Key facts

We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. Here are some of our key facts and milestones on the way to achieving our purpose.

  • £3.6bn

    R&D investment in 2016

  • 3

    significant approvals in 2017 – Shingrix, Trelegy Ellipta and Juluca

  • £4.5bn

    new product sales in Pharmaceuticals and Vaccines in 2016

  • 13%

    Consumer Healthcare sales in 2016 from product innovations launched over the past three years

  • £27.9bn

    total turnover in 2016

  • £7.7bn

    adjusted operating profit in 2016

  • £3.0bn

    free cash flow in 2016

  • £3.9bn

    dividends paid in 2016

  • 8bn

    packs/doses produced in 2016

  • 86%

    of employees proud to work at GSK

  • £210m

    donated in 2016 to local communities through product donations, time and cash

  • 1st

    in Access to Medicines Index all 5 times since its launch in 2008

  • 100,000

    we employ around 100,000 people in over 150 countries, with more than a third of these in emerging markets

  • 11,000+

    more than 11,000 people work in R&D in our search for new medicines, vaccines and consumer healthcare products

  • 833m

    doses of vaccines produced in 2016